Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(29%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
14%
Ph not_applicable
3
43%
Ph phase_3
3
43%

Phase Distribution

1

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 3Large-scale testing
3(42.9%)
N/ANon-phased studies
3(42.9%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(4)
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Not yet recruiting2
Recruiting2
Completed1
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (14.3%)
Phase 33 (42.9%)
N/A3 (42.9%)

Trials by Status

completed114%
not_yet_recruiting229%
unknown114%
recruiting229%
withdrawn114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DRUG
Total Trials
7